Comunicado ANVISA Nº 1 de 2020 – Authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in children ages 5 through 11 years of age

Brazil (National)

Issuing Authority: Brazilian Health Surveillance Agency (ANVISA)

Type: Law/Policy Document

Issued: December 16, 2021